Acute Ischemic Stroke Ais clinical trials

Explore recruiting acute ischemic stroke ais clinical trials.

Recruiting acute ischemic stroke ais studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Ischemic Stroke Ais trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

BRIGHT - A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in Subjects with Acute Ischemic Stroke (AIS)

Spain, Czechia, Germany, Italy, Greece, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

A Masked, Placebo-Controlled, Randomized, Pilot, Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke at the Prehospital Level Using the RACE (Rapid Arterial oCclusion Evaluation) Scale

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1b/2a Open-Label Dose-Finding Followed by Randomized, Double-Blind, Placebo-Controlled Expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of TGD001 in Patients with Acute Ischemic Stroke

Poland, Germany, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Intra-arterial t-PA infusion during mechanical thrombectomy in acute ischemic stroke: a randomized trial.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicentre study evaluating the safety of reperfusion thrombolytic therapy with intravenous recombinant tissue plasminogen activator (rtPA) for ischaemic stroke in patients on the non-vitamin K antagonist oral anticoagulant after reversing anticoagulant activity with a specific antidote.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

Romania, Hungary, Belgium, Poland, Spain, France

Phase II and Phase III (Integrated) EU CTIS Study details

Acute Ischemic Stroke Ais trials by city

Acute Ischemic Stroke Ais in Toronto Acute Ischemic Stroke Ais in Vancouver Acute Ischemic Stroke Ais in Montreal Acute Ischemic Stroke Ais in Calgary Acute Ischemic Stroke Ais in Edmonton Acute Ischemic Stroke Ais in Ottawa Acute Ischemic Stroke Ais in Winnipeg Acute Ischemic Stroke Ais in Quebec City Acute Ischemic Stroke Ais in Hamilton Acute Ischemic Stroke Ais in Kitchener Acute Ischemic Stroke Ais in London Acute Ischemic Stroke Ais in Halifax Acute Ischemic Stroke Ais in New York Acute Ischemic Stroke Ais in Los Angeles Acute Ischemic Stroke Ais in Chicago Acute Ischemic Stroke Ais in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease